Celltrion Reportedly Partnering with George Steuart Health on Sri Lankan Remsima (infliximab)

Lanka Business News is reporting that Celltrion and George Steuart Health have teamed up to launch Remsima (infliximab) in Sri Lanka.  According to the article, this is the first biosimilar available in Sri Lanka.  The article states that the launch took place at the Cinnamon Grand Colombo in Sri Lanka, and was attended by key opinion leaders representing vital segments of the medical industry including rheumatology, gastroenterology and dermatology.

 

Download PDF